Insilico Medicine, an AI-driven drug discovery company headquartered in the U.S. and Hong Kong, announced on the 24th (local ...

Three clinically available drugs could pave the way for safer and more effective treatments for one of the most aggressive ...

Three clinically available drugs could pave the way for safer and more effective treatments for one of the most aggressive ...

Senescent cells walk a tightrope, risking cell death with high levels of iron and other damaging agents, but compensating for this by overproducing a protective protein, GPX4, which staves off death.

Medicare Part D, an optional component of Medicare, helps beneficiaries pay for generic and name-brand prescription drugs. A Low Income Subsidy (LIS) can provide financial support to enrollees with ...

A KAIST research team has identified the real reason why anticancer drugs kill cancer cells—targeted anticancer therapies do ...

Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.

Launch prices for Medicare Part D anticancer drugs have risen sharply since 2012, with a mean increase of $1694 per year. In 2025, the observed prices were 15%-200% higher than expected if the ...

A new study on the genetic causes of the PTEN Hamartoma Tumour Syndrome (PHTS) has found that inhibitors of the PI3ka pathway, commonly used as anticancer drugs, are also effective against this ...

The latest map of all the genes involved in a set of tumor cells exposes which mutations drive cancer and how to possibly treat them.more The Human Genome Project provided the first glimpse of the ...